home · filing · 0000105770-26-000080
8-K filed June 1, 2026, 4:32 PM ET
ticker WST
CIK 0000105770
leadership
confidence high
sentiment neutral
materiality 0.70
West Pharmaceutical appoints Michel Lagarde as CEO; Green retires, Friel becomes Chair
WEST PHARMACEUTICAL SERVICES INC
Michel Lagarde appointed President & CEO of West Pharmaceutical, effective Aug 31, 2026.
Eric Green retires as President, CEO and Board Chair; Robert F. Friel becomes Board Chair.
Employment agreement: $1,175,000 base salary; target annual incentive 125% of base; 2026 LTI grant valued at $8,611,111.
Lagarde receives inducement equity awards up to $10M, including sign-on grant of $6,875,000 and matching RSUs/options.
Lagarde previously served as EVP & COO at Thermo Fisher Scientific; holds BBA from European University Antwerp.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2026-08-31
Filed June 1, 2026, 4:32 PM ET
As of the Start Date, Mr. Green will resign as a member of the Board and Mr. Lagarde will be appointed as a member of the Board to fill that vacancy.
Effective 2026-08-31
Successor Michel Lagarde
Filed June 1, 2026, 4:32 PM ET
As of the Start Date, Mr. Green will resign as a member of the Board and Mr. Lagarde will be appointed as a member of the Board to fill that vacancy.
Effective 2026-08-31
Filed June 1, 2026, 4:32 PM ET
On June 1, 2026, the Company announced the appointment of Michel Lagarde as President and Chief Executive Officer of the Company, effective August 31, 2026 (the “Start Date”), to replace Mr. Green in those roles.
Effective 2026-08-31
Filed June 1, 2026, 4:32 PM ET
As of the Start Date, Lead Independent Director Robert F. Friel will become Chair of the Board.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Michel Lagarde was appointed as member of the Board at WEST PHARMACEUTICAL SERVICES INC.
Action appointed
Role member of the Board
Exact text from the filing
As of the Start Date, Mr. Green will resign as a member of the Board and Mr. Lagarde will be appointed as a member of the Board to fill that vacancy.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Eric M. Green resigned as member of the Board at WEST PHARMACEUTICAL SERVICES INC.
Action resigned
Role member of the Board
Exact text from the filing
As of the Start Date, Mr. Green will resign as a member of the Board and Mr. Lagarde will be appointed as a member of the Board to fill that vacancy.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Michel Lagarde was appointed as President and Chief Executive Officer at WEST PHARMACEUTICAL SERVICES INC.
Action appointed
Role President and Chief Executive Officer
Exact text from the filing
On June 1, 2026, the Company announced the appointment of Michel Lagarde as President and Chief Executive Officer of the Company, effective August 31, 2026 (the “Start Date”), to replace Mr. Green in those roles.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.9
Robert F. Friel was appointed as Chair of the Board at WEST PHARMACEUTICAL SERVICES INC.
Action become
Role Chair of the Board
Exact text from the filing
As of the Start Date, Lead Independent Director Robert F. Friel will become Chair of the Board.
View on SEC.gov
Source: SEC EDGAR
accession 0000105770-26-000080
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.